These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22487835)

  • 1. [Correlation between serum anti-P53 and familial clustering of hepatocellular carcinoma in Guangxi].
    Pang Y; Li GJ; Wu JZ; Wu JL; Chen WQ; Ning QY; Wei YH; Hu DF; Qin L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):206-9. PubMed ID: 22487835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
    Saffroy R; Lelong JC; Azoulay D; Salvucci M; Reynes M; Bismuth H; Debuire B; Lemoine A
    Br J Cancer; 1999 Feb; 79(3-4):604-10. PubMed ID: 10027337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V; Vaysse J; Chevret S; Ganne-Carrie N; Christidis C; Trinchet J; Beaugrand M
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the relationship between familial clustering of hepatocellular carcinoma and polymorphism of cytochrome P450 2E1 gene in Zhuang population, Guangxi].
    Sheng Y; Huang TR; Zhang ZQ; Deng W; Yu JH; Zhang CY; Zhou DN; Li JL; Ye SY; Liang RX; Wei ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):151-5. PubMed ID: 19565876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pattern and prognostic implications of anti-p53 in hepatocellular carcinoma.
    Akere A; Otegbayo JA
    Singapore Med J; 2007 Jan; 48(1):41-4. PubMed ID: 17245515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.
    Yang Y; Jin L; He YL; Wang K; Ma XH; Wang J; Yan Z; Feng YL; Li YQ; Chen TY; Liu HL; Zhao YR
    J Med Virol; 2013 Nov; 85(11):1893-9. PubMed ID: 23934703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.
    Atta MM; el-Masry SA; Abdel-Hameed M; Baiomy HA; Ramadan NE
    Clin Biochem; 2008 Oct; 41(14-15):1131-9. PubMed ID: 18616935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
    Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR
    Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
    Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
    Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
    Shiota G; Kishimoto Y; Suyama A; Okubo M; Katayama S; Harada K; Ishida M; Hori K; Suou T; Kawasaki H
    J Hepatol; 1997 Oct; 27(4):661-8. PubMed ID: 9365042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of familial case histories of hepatocellular carcinoma--285 cases in Saga Prefectural Hospital].
    Miyanaga O; Shirahama M; Ishibashi H
    Gan No Rinsho; 1990 Feb; 36(2):127-31. PubMed ID: 2155331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
    Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma.
    Tangkijvanich P; Janchai A; Charuruks N; Kullavanijaya P; Theamboonlers A; Hirsch P; Poovorawan Y
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):237-43. PubMed ID: 11316045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-p53 autoantibodies in hepatitis C virus-infected patients.
    Raedle J; Oremek G; Roth WK; Caspary WF; Zeuzem S
    Anticancer Res; 1997; 17(4B):3079-81. PubMed ID: 9329606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.